Donate to Science & Enterprise

S&E on Mastodon

S&E on LinkedIn

S&E on Flipboard

Please share Science & Enterprise

Trial Shows Broad Coronavirus Immune Response

Southern bentwing bat

Initial results from a clinical trial show an experimental vaccine produces immune responses in healthy adults against Covid-19 variants and a range of other coronaviruses. . . . → Read More: Trial Shows Broad Coronavirus Immune Response

HHS Directs $100M for Covid-19 Venture Investments

Global Covid-19

The Department of Health and Human Services is allocating $100 million for venture investments in new technologies to prepare for future threats from Covid-19. . . . → Read More: HHS Directs $100M for Covid-19 Venture Investments

NIH Funding Single Home Test for Covid-19, Influenza, RSV

Co-Dx PCR Home test

A developer of diagnostics for infectious and other diseases is receiving a National Institutes of Health contract to advance a single at-home test for multiple respiratory diseases. . . . → Read More: NIH Funding Single Home Test for Covid-19, Influenza, RSV

Vaccine Patch Shown Safe, Induces Immune Response

Nanopatch system

Initial results from a clinical trial show a patch device delivering a Covid-19 vaccine is well tolerated by recipients and triggers a measurable immune response. . . . → Read More: Vaccine Patch Shown Safe, Induces Immune Response

Infographic – More US Support for Childhood Vaccines Than Covid-19

Bar charts: U.S. opinion on MMR and Covid-19 vaccines

A recent poll shows U.S. adults continue to favor vaccinations against the childhood diseases mumps, measles, and rubella, but show less support for Covid-19 vaccines. . . . → Read More: Infographic – More US Support for Childhood Vaccines Than Covid-19

Low-Dose Covid-19 Vaccine Generates Strong Immune Response

Exosome illustration

Ultra-low quantities of an experimental Covid-19 protein vaccine delivered in synthetic cell components are shown in lab animals to generate strong immune responses. . . . → Read More: Low-Dose Covid-19 Vaccine Generates Strong Immune Response

Biotech Gains $53.7M Infectious Disease Test Award

SARS-Cov-2 virus

A maker of diagnostics for infectious diseases is receiving a $53.7 million contract to develop and validate reliable home molecular tests for Covid-19 and flu infections. . . . → Read More: Biotech Gains $53.7M Infectious Disease Test Award

Self-Applied Patch Shown Feasible for Vaccine Delivery

Vaccine patch

A clinical trial shows a microneedle patch device for vaccine delivery applied by participants to their own arms works as well in the skin as when administered by clinicians. . . . → Read More: Self-Applied Patch Shown Feasible for Vaccine Delivery

Chewable Covid-19 Drug Reduces Viral Load, Symptoms

Global Covid-19

Clinical trial results show an experimental drug given as a chewable tablet reduces viral load and symptoms in people with mild to moderate Covid-19 disease. . . . → Read More: Chewable Covid-19 Drug Reduces Viral Load, Symptoms

Home Infectious Disease Diagnostic Begins Clinical Tests

Co-Dx PCR Home test

A company offering DNA analysis tests to detect infectious diseases at home and point-of-care is beginning clinical evaluations of its technology. . . . → Read More: Home Infectious Disease Diagnostic Begins Clinical Tests